Mycophenolate Mofetil for Injection (0.5?g per vial, 10 vials per box) is an intravenous lyophilized form of MMF manufactured by Shuanghe Pharma (Hainan), approved under ?H20067745. Used extensively in research on organ transplant rejection prevention, autoimmune pathway inhibition, and inflammatory signaling models. Supports wholesale & retail.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00Prednisone Acetate Tablets contain 5?mg active ingredient per tablet, 1000 tablets per bottle. Manufactured by Foshan Shouxin Pharmaceutical Co., Ltd., approved under license H44021207. Widely used in laboratory research to model glucocorticoid-mediated immunosuppression, inflammation control, and endocrine immune pathways. Wholesale & retail supported.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00Gamifant (emapalumab?lzsg) is a human IgG1 monoclonal antibody that neutralizes interferon?gamma (IFN?). Supplied as 10?mg in 2?ml sterile injection vial. Produced by Patheon Italia under Chinese approval SJ20220008. Used in research on cytokine storm, macrophage activation, hemophagocytic lymphohistiocytosis (HLH) modeling. For laboratory research use only.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00
Days
Hrs
Mins
Sec
Explore our high quality and low price products from China.
Shop Now
At worst the discussion is at least working towards the final goal of your site where questions about lorem ipsum don’t.
Introduction Semaglutide, marketed as Ozempic for type 2 diabetes (T2DM) and Wegovy for chronic weight management, is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the incretin hormone GLP-1, enhancing…
Read moreIntroduction Lorlatinib, also known by its brand name Lorbrena, is a third-generation tyrosine kinase inhibitor (TKI) designed to treat ALK-positive non-small cell lung cancer (NSCLC) and ROS1-positive NSCLC. Unlike earlier…
Read moreIntroduction Wegovy® (semaglutide 2.4 mg) is a breakthrough GLP-1 receptor agonist approved for chronic weight management and cardiovascular risk reduction in adults with obesity or overweight. While it offers significant benefits, understanding its potential side effects is crucial for…
Read moreIntroduction Semaglutide, marketed under the brand name Wegovy®, is a groundbreaking GLP-1 receptor agonist initially developed for type 2 diabetes management but now widely recognized for its weight loss and cardiovascular benefits. The 2.4 mg injection is an…
Read more
